Gilead Faces Fights Over Hepatitis C and H.I.V. Drugs

The company may face legal action in Massachusetts unless it drops prices for its hepatitis C drugs. In California, it is being sued over patents for an H.I.V. treatment.











from NYT > Health http://ift.tt/1lWK4gE
via health&fitness